Fidelity Investments
LNAI

Fidelity Investments’s Lunai Bioworks LNAI Stock Holding History

Fidelity Investments’s Portfolio LNAI Stock Details LNAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-52
Closed -$1.21K – 5550
2025
Q2 		$1.21K Sell
52
-226
-81% -$6.31K ﹤0.01% 4939
2025
Q1 		$12.1K Buy
278
+87
+46% +$5.57K ﹤0.01% 4436
2024
Q4 		$12.7K Buy
191
+141
+282% +$9.36K ﹤0.01% 4372
2024
Q3 		$1.95K Buy
+50
New +$3.47K ﹤0.01% 4817
2023
Q3 		– Sell
-10
Closed -$469 – 5478
2023
Q2 		$469 Sell
10
-43
-81% -$3.3K ﹤0.01% 4814
2023
Q1 		$3.84K Buy
53
+37
+231% +$3.26K ﹤0.01% 4456
2022
Q4 		$1.33K Sell
16
-6
-27% -$805 ﹤0.01% 4601
2022
Q3 		$3K Buy
22
+3
+16% +$547 ﹤0.01% 4488
2022
Q2 		$3K Hold
19
– – ﹤0.01% 4484
2022
Q1 		$13K Buy
+19
New +$10.1K ﹤0.01% 4165

Other funds holding LNAI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Fidelity Investments's LNAI Position: Q3 2025 in Review

Fidelity Investments sold out of Lunai Bioworks (LNAI) in Q3 2025, closing a stake of 52 shares — an estimated $1.21K sold.

Fidelity Investments first reported a position in LNAI in Q1 2022 and held it in 10 quarters. The position peaked at $13K in Q1 2022. 20 funds tracked by Wall St. Rank hold LNAI as of Q3 2025.

  • Fidelity Investments reported no remaining Lunai Bioworks position as of Q3 2025 after selling out during the quarter.
  • Fidelity Investments sold 52 Lunai Bioworks shares in Q3 2025, an estimated $1.21K.
  • Fidelity Investments first reported a position in Lunai Bioworks in Q1 2022 and held it in 10 quarters.
  • Fidelity Investments's Lunai Bioworks position peaked at $13K in Q1 2022.
  • 20 funds tracked by Wall St. Rank held Lunai Bioworks as of Q3 2025.

Based on Fidelity Investments's 13F filing for Q3 2025, filed 13 Nov 2025.